Predictors of outcomes of recovery following total hip replacement surgery : A prospective study by McHugh, GA et al.
VOL. 2, No. 11, NOVEMBER 2013 248
 HIP
Predictors of outcomes of recovery 
following total hip replacement surgery
A PROSPECTIVE STUDY
G. A. McHugh,
M. Campbell,
K. A. Luker
From School of 
Nursing, Midwifery & 
Social Work, 
University of 
Manchester, 
Manchester, United 
Kingdom
 G. A. McHugh, PhD, Senior 
Lecturer
 M. Campbell, PhD, Lecturer in 
Statistics
 K. A. Luker, FMedSci, QNI 
Professor of Community Nursing
University of Manchester, School 
of Nursing, Midwifery & Social 
Work, Jean McFarlane Building, 
Oxford Road, Manchester M13 
9PL, UK.
Correspondence should be sent 
to Dr G. A. McHugh; e-mail: 
gretl.mchugh@manchester.ac.uk
10.1302/2046-
3758.211.2000206 $2.00
Bone Joint Res 2013;2:248–54. 
Received 12 June 2013; Accepted 
after revision 18 October 2013
Objectives
To investigate psychosocial and biomedical outcomes following total hip replacement (THR) 
and to identify predictors of recovery from THR.
Methods
Patients with osteoarthritis (OA) on the waiting list for primary THR in North West England were 
assessed pre-operatively and at six and 12 months post-operatively to investigate psychosocial 
and biomedical outcomes. Psychosocial outcomes were anxiety and depression, social support 
and health-related quality of life (HRQoL). Biomedical outcomes were pain, physical function 
and stiffness. The primary outcome was the Short-Form 36 (SF-36) Health Survey Total Physical 
Function. Potential predictors of outcome were age, sex, body mass index, previous joint 
replacement, involvement in the decision for THR, any comorbidities, any complications, type of 
medication, and pre-operative ENRICHD Social Support Instrument score, Hospital Anxiety and 
Depression scores and Western Ontario and McMaster Universities osteoarthritis index score.
Results
The study included 206 patients undergoing THR. There were 88 men and 118 women 
with a mean age of 66.3 years (SD 10.4;36 to 89). Pain, stiffness and physical function, 
severity of OA, HRQoL, anxiety and depression all improved significantly from pre-
operative to 12-month assessment (all p < 0.001), with the greatest improvement occurring 
in the first six months (all p < 0.001). The predictors that were found to influence recovery 
six months after THR were: pain (p < 0.001), anxiety (p = 0.034), depression (p = 0.001), 
previous joint replacement (p = 0.006) and anti-inflammatory drugs (p = 0.012).
Conclusions
The study identified the key psychosocial and biomedical predictors of recovery following 
THR. By identifying these predictors, we are able to identify and provide more support for 
patients at risk of poor recovery following THR.
Cite this article: Bone Joint Res 2013;2:248–54.
Article focus
 To investigate the biomedical and psycho-
social outcomes following total hip replace-
ment (THR) in patients with osteoarthritis
 To determine which predictors are associ-
ated with better outcomes of recovery
from THR
Key messages
 Having social support does affect an indi-
vidual’s mental well-being, but does not
influence recovery following THR
 Patients with anxiety and depression are
at risk of poorer recovery following THR
 Health professionals need to be aware of
patients who are more at risk of poor
recovery from THR, so that advice and
targeted interventions can be delivered
Strengths and limitations
 Adequate sample size and low attrition
rate during follow-up
 Use of valid and reliable tools to measure
osteoarthritis symptoms and severity,
social support, anxiety and depression
and health-related quality of life
 Follow-up limited to 12 months after
THR
Freely available online
Keywords: Osteoarthritis, Hip replacement, Recovery, Patient-reported outcomes, Predictors, THR
249 G. A. MCHUGH, M. CAMPBELL, K. A. LUKER
BONE & JOINT RESEARCH
Introduction
Total hip replacement (THR) for osteoarthritis (OA) is one
of the most common operations carried out in England.1
A total of 76 970 THRs were performed in England in the
period from 2007 to 2008, which had increased to 86 076
for the period 2011 to 2012.1,2 THRs are a considerable
cost to the health service, both in terms of the operation
costs and the care and rehabilitation that patients require.
The National Institute for Health and Care Excellence
(NICE) recommends surgery when there is prolonged
and established limitation and severe pain.3 Pain and
restriction of internal rotation of the hip are found to be
the major clinical predictors of being placed on a waiting
list for hip replacement.4
Joint replacement for severe OA of the hip is an effec-
tive treatment.5 Improvements are found early in the
post-operative period, but a follow-up of 12 months is
required to gain the full benefit of THR.6 Recovery fol-
lowing THR often focuses on the long-term clinical out-
comes and there is strong evidence that biomedical
factors, such as pain and physical function, improve
after joint replacement.6-12 Despite successes in reduc-
tion of pain after THR, a recent systematic review found
that between 7% and 23% of patients report long-term
pain after THR for OA.13
Psychosocial outcomes, such as health-related quality
of life (HRQoL), are found to improve following
THR.10,11,14 However, a systematic review showed that
THR was effective resulting in an improvement in
HRQoL, but not regarding the social dimension,15 with
another study showing little or no change in HRQoL
following THR.9 Comorbidity may be an issue and can
interfere with improvements in HRQoL following hip
replacement.15
Anxiety and depression are prevalent in individuals
with osteoarthritis.16,17 Whether these psychosocial out-
comes improve post-hip replacement is an under-
researched area and a focus of this study. Pre-operative
depression and somatisation have been found to influ-
ence outcome after THR18 and pre-operative anxiety and
depression may influence post-operative pain and
HRQoL.19
There is also evidence that social support has an influ-
ence on improvements in quality of life after joint replace-
ment, although there was a limitation as to how social
support was measured.10 Qualitative research has shown
that recovery in the early stages is influenced by patients’
relationships and social support.20
It is important to identify factors that may influence
outcomes following THR so that health professionals are
able to identify those patients who may be more at risk of
poorer recovery following THR. The overall aim of this
study was to investigate the biomedical and psychosocial
outcomes following THR in patients with OA and to
determine which predictors are associated with better
outcomes of recovery from THR.
Patients and Methods
The study was longitudinal, with a postal questionnaire
completed pre-operatively and at six and 12 months after
THR. Ethical approval was obtained from an NHS research
ethics committee (Wrightington, Wigan & Leigh LREC:
08/H1014/40) and research governance arrangements in
NHS Trusts were followed. 
Sample size was based on having a form of multiple
regression as the main analysis to estimate associations
with a continuous HRQoL outcome.21 Assuming moder-
ate effect sizes, a significance level of 0.05 and power of
0.80, a model involving ten predictors required a sample
size of 163, allowing for attrition of up to 20% during
follow-up. While this was the initial target, the final sam-
ple size supported the estimation of models with up to
14 predictors.
Patients with OA who were placed on the waiting list
for a primary THR from three hospitals in the North
West of England were recruited for the study. Written
consent was obtained from each participant. A total of
438 individuals were invited to participate during
October 2008 to July 2009, with follow-up continuing
until 12 months after THR. As there was a delay with
some operations, follow-up was not completed until
mid-2011.
Data were collected pre-operatively and at six and
12 months post-operatively by post using a structured
questionnaire to collect information on demographics,
medication, consultation episodes, history of OA, and
pre- and post-operative complications. 
Assessment of psychosocial factors. Social support was
measured by the ENRICHD Social Support Instrument
(ESSI).22 The ESSI is a seven-item measure, with items
summed to provide a total score between 8 and 34; a
higher score is indicative of greater social support. Anxi-
ety and depression were measured using the Hospital
Anxiety and Depression Scale (HADS).23-25 The HADS anx-
iety and depression scores range between 0 and 21:
scores from 0 to 7 are ‘normal’, from 8 to 10  ‘mild’, from
11 to 15 considered ‘moderate’ and from 16 to 21 ‘severe’.
HRQoL was assessed using the Short-Form 36 Health Sur-
vey (SF-36v2), which provides two summary scores (total
physical and total mental scores), each ranging from 0 to
100, with higher scores indicating better quality of life.
Version 2 allows for norm-based scoring with a mean of
50 (SD 10).26
Assessment of biomedical factors. Pain, stiffness and
physical function were assessed using the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC).27 The WOMAC pain score ranges between
0 and 20, the stiffness score between 0 and 8 and the
physical function range between 0 and 68, with lower
scores in each being indicative of better function. The
Oxford Hip Score (OHS) was used to measure outcome
following THR.28,29 It ranges from 0 to 48, with a higher
score indicative of a better outcome.
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The measurement tools were chosen for their validity,
reliability and responsiveness to detect change. At six and
12 months following hip replacement, participants com-
pleted the WOMAC, OHS, SF-36v2 and HADS. 
Statistical analysis. Data from the questionnaires were
entered into Microsoft Excel (Microsoft Corp., Redmond,
Washington) and SPSS v20 (IBM Corp., Armonk, New
York). Descriptive and inferential statistics were used,
with a conventional significance level of α = 0.05 used to
determine statistical significance. Linear mixed models
were fitted to analyse the change in outcome measures
from pre-operative to 12-month assessment, and to see
which variables were independently associated with bet-
ter outcomes at six and 12 months post-operatively. This
approach uses data from all participants, whether or not
they had responded at each time-point.30 For simplicity,
only main effects terms were included in the model; time
was treated as a covariate and an unstructured covariance
type was used. The outcome of main interest was the
change in the SF-36 Total Physical Score at six months
post-operatively. The predictor variables for investigation
were chosen from a study of the literature. They included
age, gender, body mass index (BMI), previous joint
replacement, involvement in decision to undergo THR,
comorbidity, complications, taking opioids, taking non-
steroidal anti-inflammatory drugs (NSAIDs) or COX-2
inhibitors, and baseline scores (including ENRICHD social
support score, HADS anxiety score, HADs depression
score and WOMAC pain level).
Results
Of the 400 eligible patients, 215 completed the baseline
questionnaire (baseline participation rate 53.8%). Of
these, nine did not go on to have their operation, leaving
206 patients included in the study. A total of 188 patients
completed the six-month follow-up and 182 completed
the 12-month follow-up (Fig. 1). 
Baseline characteristics for all 206 participants who had
a THR are given in Table I. There were 88 men and
118 women with a mean age of 66.3 years (SD 10.4; 36 to
89), of whom 135 (66.2%) were overweight (BMI > 25 kg/
m2), with 51 (25.0%) classified as obese (BMI > 30 kg/m2)
according to the World Health Organization (WHO) classi-
fication.31 Of the 206 participants, 178 (86.4%) completed
Invited to participate 
(n = 438)  
Completed baseline questionnaire 
(n = 215)
Did not receive THR (n = 9) 
Revised number of baseline participants
(n = 206) 
Six-month follow-up 
(n = 188) 
Missed six-month follow-up (n = 18) 
 Moved (2) 
 Too ill (2) 
 Non-responders (14) 
12-month follow-up  
(n = 182) 
Rejoined study after missed six-month follow-up (n = 4)  
Missed 12-month follow-up (n = 10) 
 Died (1) 
 Too ill (1) 
 Non-responders (8)
Exclusions (n = 38)
 Already had THR (16)
 Mental incapacity (2)
 Not osteoarthritis (2)
 Not THR (5)
 Died (1)
 Too ill (5)
 Wrong address (7)
Non-participation (n = 185)
 Non-responders (177)
 Refused (8)
Fig. 1
Recruitment flowchart.
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the questionnaires pre-operatively and at both follow-up
time-points, and 188 patients (91.3%) provided both pre-
operative and six-month data. Compared with participants
with complete data, those with incomplete data showed
no significant difference in their baseline characteristics,
but they had significantly worse WOMAC scores (pain
p = 0.006, stiffness p = 0.024, physical function p = 0.010),
SF-36 Total Mental Score (p = 0.017) and HADS depression
scores (p = 0.039) at baseline.
Social support was measured using the ESSI at base-
line. The median score was 27 (interquartile range (IQR)
22 to 30), with 18 (8.4%) scoring ≤ 15 and 79 (38.9%)
scoring 29 or 30. At baseline, the median ESSI was sig-
nificantly higher for males than females (28 (IQR 24 to
30) vs 26 (IQR 21 to 29)); p = 0.003, Mann–Whitney U
test), and significantly correlated with HADS anxiety
(Kendall’s τ = -0.15, p = 0.004) and depression scores
(τ = -0.17, p = 0.001). In particular, it was not signifi-
cantly associated with the SF-36 Total Physical Score at
baseline, six or 12 months (p = 0.891, 0.478 and 0.539,
respectively), although it was significantly associated
with the SF-36 Total Mental Score (p < 0.001, p = 0.001
and p = 0.004, respectively).
The median hospital stay was six days (IQR 3 to 42). Of
the 198 responding to the question, 62 patients (31.3%)
reported a delay in being discharged and of these, only
three had anticipated this delay. A total of 22 patients
(10.7%) had post-operative complications (infection in
nine, bleeding in nine, dislocation in three and throm-
bosis in one).
WOMAC pain, stiffness and physical function scores,
OHS, SF-36 Total Physical and Mental Scores, and HADS
anxiety and depression scores all showed a significant
improvement from before the operation to 12 months
after the operation (all p < 0.001), with most improve-
ment occurring in the first six months (all p < 0.001)
(Table II). The OHS was the only measure which
approached a statistically significant change from
six months to 12 months (p = 0.089).
A number of variables were identified as important pre-
dictors of the SF-36 Total Physical Score at six months
(Table III). In addition to the expected relationship with
the pre-operative Total Physical Score (p < 0.001), change
in Total Physical Score at six months was significantly and
negatively associated with baseline HADS anxiety and
depression scores and WOMAC pain score at baseline
(p = 0.034, p = 0.001 and p < 0.001, respectively). Those
with previous experience of joint replacement surgery
also had significantly worse outcomes (p = 0.006), while
those taking NSAIDs or COX-2 inhibitors had significantly
better outcomes (p = 0.012). The association between
change in Total Physical Score at six months and taking
opioids was negative but just failed to reach significance
(p = 0.054). There was a similar pattern of association at
12 months, with a less significant association between
change in Total Physical Score at six months and taking
opioids (p = 0.176).
Discussion
This study investigated the psychosocial and biomedical
outcomes following THR. We were able to ascertain the
predictors of recovery following THR. The predictor posi-
tively related to recovery was the taking of anti-
inflammatory drug consumption and those that had a
negative effect on recovery included anxiety and depres-
sion, pain and previous experience of joint replacement.
There were few post-operative complications following
THR in the study participants.
Biomedical outcomes such as pain, physical function,
stiffness improved significantly in patients by six months’
post-operatively. Previous studies have shown improve-
ments in pain and physical function following hip
replacement,6,8,11 with one study showing that greatest
improvement in pain, physical function and stiffness fol-
lowing THR occurred by three months.8 It is of interest
that the OHS, which is validated for measuring outcome
following joint replacement, was the only outcome mea-
sure for which the change from six to 12 months
approached statistical significance. This may be as a result
of its use as a joint-specific instrument that was devel-
oped to minimise the effects of comorbidity.29 The instru-
ment is also sensitive to the outcome of joint replacement
and is responsive to detecting changes.32 When the OHS
has been compared with the WOMAC, the former
appears to be less influenced by the presence of other
comorbidities.33
The psychosocial outcomes such as HRQoL, anxiety and
depression improved significantly at six months following
Table I. Baseline characteristics of all participants
Characteristic
Patients (n) 206
Male (n, %) 88 (42.7)
Mean age (yrs) (SD; range) 66.3 (10.4; 36 to 89)
Married/living together (n, %) 142 (68.9)
Mean body mass index (kg/m2) (SD; range) 27.5 (5.3; 13.0 to 47.9)
Smoker (n, %) 24 (11.7)
Mean cigarettes/day (SD; range) 10.7 (5.7; 0 to 20)
Comorbidities (n, %) 159 (77.2)
Mean number (SD; range) 1.4 (1.3; 1 to 7)
Median number 1
Angina 20 (9.7)
Ankylosing spondylitis 9 (4.4)
Anxiety-related 14 (6.8)
Asthma 23 (11.2)
Bronchitis 7 (3.4)
Depression-related 16 (7.8)
Diabetes 22 (10.7)
Gastro-intestinal 25 (12.1)
Hypertension 86 (41.7)
Rheumatoid arthritis 17 (8.3)
Other illness(es) 46 (22.3)
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THR. HRQoL has previously been found to be slower to
improve post-operatively than pain or physical function.8
Our study found significant improvements in HRQoL at
six months after THR. Anxiety and depression have not
been investigated extensively in patients undergoing THR.
The baseline levels of anxiety and depression in our study
(mean HADS scores of 7.6 and 7.4, respectively) were just
outside the normal range (defined as 0 to 7), thereby
bordering on the category of mild anxiety and depression.
Once patients had a THR, our study found that there were
significant improvements in both anxiety and depression,
which were also identified as predictors influencing
recovery. Those patients who had higher anxiety and
depression scores as measured by HADs had a worse out-
come. Levels of anxiety pre-operatively may partly be due
to apprehension about their impending operation, thus
support and interventions aimed at reducing this anxiety
could be helpful to these patients. Previously, mental
health has been found to influence HRQoL outcome.34
Therefore, it is important that anxiety and depression are
assessed pre-operatively to identify undiagnosed depres-
sion and anxious patients.
Another predictor of recovery was pain. Pain has previ-
ously been reported as a predictor of outcome following
THR, with a higher level of pain associated with poorer
outcome9 and this study confirms this. Previously,
Table II. Changes in validated measures from pre-operative assessment to six and 12 months post-operatively using linear mixed model (n = 206)
Mean (SD) score Change over time p-values (Sidak-corrected)
Outcome
measure
Pre-operative 
(n = 206)
6 months 
(n = 188)
12 months
(n = 181) F df p-value
Pre vs 
6 mths 
Pre vs 
12 mths
6 vs 
12 mths
WOMAC*
Pain 11.4 (3.7) 3.1 (3.8) 2.7 (3.7) 375.62 2, 660.66 < 0.001 < 0.001 < 0.001 0.280
Stiffness 4.9 (1.6) 2.2 (1.6) 2.0 (1.7) 281.77 2, 383.37 < 0.001 < 0.001 < 0.001 0.224
Physical function 40.5 (12.7) 15.7 (13.6) 15.3 (14.0) 370.65 2, 370.65 < 0.001 < 0.001 < 0.001 0.751
OHS† 18.5 (8.1) 36.8 (9.6) 37.9 (9.5) 631.28 2, 374.50 < 0.001 < 0.001 < 0.001 0.089
SF-36‡
Total Physical Score 28.2 (8.5) 40.1 (11.1) 40.9 (11.6) 233.15 2, 375.70 < 0.001 < 0.001 < 0.001 0.471
Total Mental Score 47.2 (14.0) 50.7 (12.1) 50.4 (13.3) 9.70 2, 369.77 < 0.001 < 0.001 0.002 0.933
HADS§
Anxiety score 7.6 (4.6) 4.8 (4.3) 4.9 (4.5) 81.19 2, 372.72 < 0.001 < 0.001 < 0.001 0.698
Depression score 7.4 (3.9) 4.1 (3.8) 3.8 (3.8) 132.16 2, 369.14 < 0.001 < 0.001 < 0.001 0.846
* WOMAC, Western Ontario and McMaster Universities osteoarthritis index: pain (0 to 20), stiffness (0 to 8) and physical function (0 to 68) subscores, with
lower scores indicating better function 
† OHS, Oxford hip score (0 to 48, higher score indicating better outcome following THR)
‡ SF-36, Short-Form 36: Total Physical and Total Mental Scores (both from 0 to 100), with higher scores indicating better quality of life and norm-based
scoring with a mean of 50 (SD 10) 
§ HADS, Hospital Anxiety and Depression Scale: anxiety (0 to 21) and depression (0 to 21), each graded as normal (0 to 7), mild (8 to 10), moderate (11 to
15) and severe (16 to 21)
Table III. Predictors of Short-Form 36 (SF-36) Total Physical Score at six and 12 months post-operatively using linear mixed models
(n = 198). Statistically significant p-values are bolded (CI, confidence interval)
Six months 12 months
Predictor Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Constant 44.19 - 44.88 -
Age -0.01 (-0.10 to 0.09) 0.871 -0.01 (-0.10 to 0.09) 0.916
Female 1.63 (-0.34 to 3.61) 0.104 0.98 (-1.03 to 3.00) 0.338
Body mass index 0.15 (-0.02 to 0.33) 0.091 0.14 (-0.04 to 0.32) 0.132
ENRICHD Social Support score -0.08 (-0.26 to 0.09) 0.360 -0.09 (-0.27 to 0.09) 0.335
Previous joint surgery -2.98 (-5.07 to -0.88) 0.006 -2.71 (-4.85 to -0.57) 0.013
Involved in decision -1.18 (-3.18 to 0.82) 0.247 -1.07 (-3.11 to 0.97) 0.301
Any comorbidities -1.72 (-4.00 to 0.56) 0.138 -1.12 (-3.45 to 1.21) 0.344
Any complications -1.43 (-1.43 to 3.55) 0.402 0.37 (-2.20 to 2.94) 0.778
Taking opioids -1.94 (-3.92 to 0.03) 0.054 -1.39 (-3.41 to 0.63) 0.176
Taking NSAIDs or COX-2 inhibitors 2.41 (0.55 to 4.27) 0.012 2.64 (0.73 to 4.54) 0.007
HADS anxiety score at baseline 0.28 (0.02 to 0.54) 0.034 0.38 (0.12 to 0.64) 0.004
HADS depression score at baseline -0.56 (-0.56 to -0.16) 0.001 -0.65 (-0.98 to -0.31) < 0.001
WOMAC pain score at baseline -1.19 (-1.48 to -0.91) < 0.001 -1.28 (-1.57 to -0.99) < 0.001
SF-36 Total Physical Score over time -11.42 (-12.82 to -10.03) < 0.001 -12.19 (-13.64 to -10.75) < 0.001
* NSAIDs, non-steroidal anti-inflammatory drugs; HADS, Hospital Anxiety and Depression Scale; WOMAC, Western Ontario and
McMaster Universities osteoarthritis index; SF-36, Short-Form 36
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patients with higher baseline function have been found
to have less pain and better function at six months than
those with lower baseline function.35 Ensuring that
patients have appropriate information as well as access to
treatments to reduce pain pre-operatively and post-
operatively would be useful.
Taking NSAIDs were found to be a predictor of recovery
following THR but taking weak or strong opioids was not
a statistically significant predictor (just missing statistical
significance at six months: p = 0.054). The use of medica-
tion for OA is variable and one study of patients with end-
stage OA awaiting joint replacement found that patients
often do not take adequate analgesia, or are taking
analgesics which are ineffective in relation to their level of
pain.36 Ensuring that patients have their medication
assessed regularly and understanding how to take their
medication is important during recovery from THR.
In individuals who previously had another joint
replaced, this was found to influence recovery negatively.
Only one study was identified which looked at previous
joint procedures and this study found that patients with
previous knee surgery undergoing THR had significantly
lower improvements in physical and social functioning,
but this was not found in previous hip surgery patients.37
It has also been shown that in patients having a THR,
those with OA of the non-operative hip have less long-
term improvement in function.9 Therefore, it is important
to recognise that those individuals who have OA in other
joints or previous joint replacements, may not have as
much functional improvement as individuals who only
have hip OA in the joint replaced.
There were a number of variables that did not influence
recovery following THR and some of these are worthy of
further discussion. The concept of social support has not
been extensively studied in patients with OA or what
influence having social support has on recovery follow-
ing joint replacement. Only one study of individuals hav-
ing a hip replacement has been identified and this found
that having greater social support resulted in better post-
operative outcomes.10 However, the research was limited
by the way social support was measured, which was:
married/not married and living alone/not living alone.
There has been more extensive work using ESSI as a mea-
sure of social support with cardiac patients and having
social support was an important predictor of recovery fol-
lowing myocardial infarction.38 We hypothesised that
having social support would positively influence recovery
following THR. However, social support as measured by
the ESSI at baseline was not a predictor of outcome fol-
lowing THR. Despite, the ESSI being a valid and reliable
instrument to measure social support, it may not have
been the best measure to use with the OA population, as
the instrument has mainly been used to measure social
support with cardiac patients.22,38 Perhaps the Medical
Outcomes Study (MOS) Social Support Survey instru-
ment developed for individuals with chronic diseases39
might have been more appropriate to use in our popula-
tion but the ESSI was selected over this instrument
because of its applicability with surgical patients. Further
research is needed on social support and its influence on
recovery. We have shown that there are correlations
between ESSI and TMS and between ESSI and HADS, so it
would be important to use mental well-being as an out-
come. Previous qualitative research has found that social
support is important for patients during recovery follow-
ing hip replacement20,40 and it is also important to those
in deciding to undergo joint replacement surgery.41,42
Weight management is important for patients with OA
and guidelines from NICE recommend interventions to
achieve weight loss as a core treatment for individuals
with OA.3 It is of concern that two-thirds of patients
undergoing THR were overweight, with around a quarter
of participants classed as obese (BMI > 30 kg/m2). How-
ever, BMI was not found to be a predictor of post-opera-
tive outcome in THR and this is consistent with another
study.10 However, in the longer term it is unclear in those
with a THR, the effects of being obese on mobility, physi-
cal functioning and on the replaced hip joint. One study
of longer-term outcomes found that a high BMI and
worse physical function pre-operatively were predictors
for worse function at a follow-up of 3.6 years.9
Pre-operative comorbidity did not predict worse recov-
ery. This supports the findings of a previous study that
found comorbid conditions were not predictive of worse
outcome using WOMAC function as primary outcome
and also with SF-36 Total Physical Score as the primary
outcome.6 Other studies have shown that having comor-
bidity had worse outcomes following THR.19,34 and influ-
enced the longer-term functional outcome of THR.43
The strength of this study was that participants were
recruited from three study sites with different proce-
dures for patients undergoing THR, thus making the
study findings more generalisable. The study used reli-
able and valid measurement instruments. The use of the
SF-36 Total Physical Score at six months as the outcome
is also a strength of the study, as it has been shown to be
as responsive as the disease-specific measures (such as
WOMAC or the OHS)44 and shows a better gradient with
comorbidities.9 The study was adequately powered to
80% for the main analysis, with the required sample size
achieved. There was a lower attrition rate than was esti-
mated at follow-ups of six and 12 months. A limitation of
the study was the 46% rate of non-participation, which
was largely affected by a poor response in one of the
study sites. Another limitation was the loss of patients at
each time period. Follow-up was also limited to the two
time-points of six and 12 months, which did not allow
for early post-operative outcomes and longer-term
outcomes of THR to be assessed. Finally, using another
measurement tool to assess social support other than
the ESSI, which has mainly been used in the cardiac pop-
ulation, may have been more appropriate.
PREDICTORS OF OUTCOMES OF RECOVERY FOLLOWING TOTAL HIP REPLACEMENT SURGERY 254
VOL. 2, No. 11, NOVEMBER 2013
Achieving optimum recovery for patients following a THR
is important. We have shown that patients do experience
improvement in psychosocial and biomedical outcomes at
six months after hip replacement. The strongest predictors
of recovery were: anxiety and depression; pain, previous
joint surgery and taking anti-inflammatory drugs. The iden-
tification of predictors affecting outcome of recovery will
assist in providing guidance to health professionals and
patients on how to enhance recovery following THR. 
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